Research Advances on Tilapia Streptococcosis
<i>Streptococcus agalactiae</i>, often referred to as group B streptococci (GBS), is a severe pathogen that can infect humans as well as other animals, including tilapia, which is extremely popular in commercial aquaculture. This pathogen causes enormous pecuniary loss, and typical sympt...
Main Author: | Ze Zhang |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-05-01
|
Series: | Pathogens |
Subjects: | |
Online Access: | https://www.mdpi.com/2076-0817/10/5/558 |
Similar Items
-
Development and evaluation of recombinant vector cells carrying cell wall surface anchor family proteins as a vaccine against streptococcosis in red hybrid tilapia (Oreochromis SPP)
by: Mansor, Nur Nazifah
Published: (2013) -
Administration of Microencapsulated Probiotic at Different Doses to Control Streptococcosis in Tilapia (Oreochromis niloticus)
by: DIAH AYU SATYARI UTAMI, et al.
Published: (2015-03-01) -
Administration of Microencapsulated Probiotic at Different Doses to Control Streptococcosis in Tilapia (Oreochromis niloticus)
by: DIAH AYU SATYARI UTAMI, et al.
Published: (2015-03-01) -
Development of formalin killed vaccine candidate against streptococcosis caused by Enterococcus sp. in Nile tilapia
by: Tasmina Akter, et al.
Published: (2022-12-01) -
Multiplex PCR for simultaneous detection of Streptococcus agalactiae, Streptococcus iniae and Lactococcus garvieae: a case of S. agalactiae infection in cultured Nile tilapia (Oreochromis niloticus) and red tilapia (Oreochromis niloticus x Oreochromis mossambicus)
by: Chutima Tantikitti, et al.
Published: (2012-11-01)